TY - CHAP AU - Willemze, R. AU - Paulli, M. AU - Kadin, M. E. ED - Swerdlow, S. H. ED - Campo, E. ED - Harris, N. L. ED - Jaffe, E. S. PY - 2017 DA - 2017// TI - Primary cutaneous CD30-positive T-cell lymphoproliferative disorders BT - WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Revised 4th edition) PB - IARC CY - Lyon ID - Willemze2017 ER - TY - JOUR AU - Willemze, R. AU - Jaffe, E. S. AU - Burg, G. PY - 2005 DA - 2005// TI - WHO-EORTC classification for cutaneous lymphoma JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-09-3502 DO - 10.1182/blood-2004-09-3502 ID - Willemze2005 ER - TY - JOUR AU - Bekkenk, M. W. AU - Geelen, F. A. AU - Voorst Vander, P. C. PY - 2000 DA - 2000// TI - Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch cutaneous lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment JO - Blood VL - 95 UR - https://doi.org/10.1182/blood.V95.12.3653.012k23_3653_3661 DO - 10.1182/blood.V95.12.3653.012k23_3653_3661 ID - Bekkenk2000 ER - TY - JOUR AU - Kempf, W. PY - 2017 DA - 2017// TI - A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders JO - Semin Diagn Pathol VL - 34 UR - https://doi.org/10.1053/j.semdp.2016.11.005 DO - 10.1053/j.semdp.2016.11.005 ID - Kempf2017 ER - TY - JOUR AU - Rabinovich, G. A. AU - Gabrilovich, D. AU - Sotomayor, E. M. PY - 2007 DA - 2007// TI - Immunosuppressive strategies that are mediated by tumor cells JO - Annu Rev Immunol VL - 25 UR - https://doi.org/10.1146/annurev.immunol.25.022106.141609 DO - 10.1146/annurev.immunol.25.022106.141609 ID - Rabinovich2007 ER - TY - JOUR AU - Wilcox, R. A. AU - Feldman, A. L. AU - Wada, D. A. PY - 2009 DA - 2009// TI - B7-H1 (PD-L1, CD274) suppress host immunity in T-cell lymphoproliferative disorders JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-04-216671 DO - 10.1182/blood-2009-04-216671 ID - Wilcox2009 ER - TY - JOUR AU - Pauken, K. E. AU - Wherry, J. PY - 2015 DA - 2015// TI - Overcoming T cell exhaustion in infection and cancer JO - Trends Immunol VL - 36 UR - https://doi.org/10.1016/j.it.2015.02.008 DO - 10.1016/j.it.2015.02.008 ID - Pauken2015 ER - TY - JOUR AU - Tanaka, A. AU - Sakaguchi, S. PY - 2017 DA - 2017// TI - Regulatory T cells in cancer immunotherapy JO - Cell Res VL - 27 UR - https://doi.org/10.1038/cr.2016.151 DO - 10.1038/cr.2016.151 ID - Tanaka2017 ER - TY - JOUR AU - Peggs, K. S. AU - Quezada, S. A. AU - Allison, J. P. PY - 2008 DA - 2008// TI - Cell intrinsic mechanisms of T-cell inhibition and application to cancer JO - Immunol Rev VL - 224 UR - https://doi.org/10.1111/j.1600-065X.2008.00649.x DO - 10.1111/j.1600-065X.2008.00649.x ID - Peggs2008 ER - TY - JOUR AU - Franciso, L. M. AU - Salinas, V. H. AU - Brown, K. E. PY - 2009 DA - 2009// TI - PD-L1 regulates the development, maintenance, and function of induced regulatory T cells JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20090847 DO - 10.1084/jem.20090847 ID - Franciso2009 ER - TY - JOUR AU - Sledzinska, A. AU - Menger, L. AU - Bergerhoff, K. PY - 2015 DA - 2015// TI - Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy JO - Mol Oncol VL - 9 UR - https://doi.org/10.1016/j.molonc.2015.10.008 DO - 10.1016/j.molonc.2015.10.008 ID - Sledzinska2015 ER - TY - JOUR AU - Fontenot, J. D. AU - Gavin, M. A. AU - Rudensky, A. Y. PY - 2003 DA - 2003// TI - Foxp3 programs the development and function of CD4+CD25+ regulatory T cells JO - Nat Immunol VL - 4 UR - https://doi.org/10.1038/ni904 DO - 10.1038/ni904 ID - Fontenot2003 ER - TY - JOUR AU - Souza, A. AU - Tinguely, M. AU - Burghart, D. R. PY - 2016 DA - 2016// TI - Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophage JO - J Cutan Pathol VL - 43 UR - https://doi.org/10.1111/cup.12719 DO - 10.1111/cup.12719 ID - Souza2016 ER - TY - JOUR AU - Gjerdrum, L. M. AU - Woetmann, A. AU - Odum, N. PY - 2007 DA - 2007// TI - FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404913 DO - 10.1038/sj.leu.2404913 ID - Gjerdrum2007 ER - TY - JOUR AU - Gjerdrum, L. M. AU - Woetmann, A. AU - Odum, N. PY - 2008 DA - 2008// TI - FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations JO - Eur J Haematol VL - 80 UR - https://doi.org/10.1111/j.1600-0609.2008.01064.x DO - 10.1111/j.1600-0609.2008.01064.x ID - Gjerdrum2008 ER - TY - JOUR AU - Kim, Y. H. AU - Willemze, R. AU - Pimpinelli, N. PY - 2007 DA - 2007// TI - TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2006-10-054601 DO - 10.1182/blood-2006-10-054601 ID - Kim2007 ER - TY - JOUR AU - Gentzler, R. AU - Hall, R. AU - Kunk, P. R. PY - 2016 DA - 2016// TI - Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors JO - Immunotherapy VL - 8 UR - https://doi.org/10.2217/imt-2015-0029 DO - 10.2217/imt-2015-0029 ID - Gentzler2016 ER - TY - JOUR AU - Shang, B. AU - Liu, Y. AU - Jiang, S. J. AU - Liu, Y. PY - 2015 DA - 2015// TI - Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep15179 DO - 10.1038/srep15179 ID - Shang2015 ER - TY - JOUR AU - Li, Z. AU - Dong, P. AU - Ren, M. PY - 2016 DA - 2016// TI - PD-L1 expression is associated with tumor FOXP3(+) regulatory T-cell infiltration of breast cancer and poor prognosis of patient JO - J Cancer VL - 7 UR - https://doi.org/10.7150/jca.14549 DO - 10.7150/jca.14549 ID - Li2016 ER - TY - JOUR AU - Zhu, Y. AU - Li, M. AU - Mu, D. AU - Kong, L. PY - 2016 DA - 2016// TI - CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer JO - Oncotarget VL - 7 ID - Zhu2016 ER - TY - JOUR AU - Que, Y. AU - Xiao, W. AU - Guan, Y. X. AU - Liang, Y. PY - 2017 DA - 2017// TI - PD-L1 expression is associated with FOXP3+ regulatory T-cell infiltration of soft tissue sarcoma and poor patient prognosis JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.18683 DO - 10.7150/jca.18683 ID - Que2017 ER - TY - JOUR AU - Carreras, J. AU - Lopes-Guillermo, A. AU - Fox, B. C. PY - 2006 DA - 2006// TI - FOXP3-positive regulatory T-cells are associated with improved overall survival in follicular lymphoma JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2006-04-018218 DO - 10.1182/blood-2006-04-018218 ID - Carreras2006 ER - TY - JOUR AU - Tzankov, A. AU - Meier, C. AU - Hirschmann, P. PY - 2008 DA - 2008// TI - Correlation of high numbers of intratumoral FOXP+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma JO - Haematologica VL - 93 UR - https://doi.org/10.3324/haematol.11702 DO - 10.3324/haematol.11702 ID - Tzankov2008 ER - TY - JOUR AU - Wang, J. AU - Ke, X. Y. PY - 2011 DA - 2011// TI - The four types of Tregs in malignant lymphomas JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-50 DO - 10.1186/1756-8722-4-50 ID - Wang2011 ER - TY - JOUR AU - Wherry, E. J. AU - Kurach, M. PY - 2015 DA - 2015// TI - Molecular and cellular insights into T cell exhaustion JO - Nature Rev Immunol VL - 15 UR - https://doi.org/10.1038/nri3862 DO - 10.1038/nri3862 ID - Wherry2015 ER - TY - JOUR AU - Gong, Y. AU - Chen, R. AU - Zhang, X. PY - 2017 DA - 2017// TI - Role of immune microenvironmental factors for improving the IPI-related risk stratification of aggressive B cell lymphoma JO - Biomed Environ Sci VL - 30 ID - Gong2017 ER - TY - JOUR AU - Roychoudhuri, R. AU - Eil, R. L. AU - Restifo, N. P. PY - 2015 DA - 2015// TI - The interplay of effector and regulatory T cells in cancer JO - Curr Opin Immunol VL - 33 UR - https://doi.org/10.1016/j.coi.2015.02.003 DO - 10.1016/j.coi.2015.02.003 ID - Roychoudhuri2015 ER - TY - JOUR AU - Yang, Z. Z. AU - Novak, A. J. AU - Ziesmer, S. C. PY - 2006 DA - 2006// TI - Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1822 DO - 10.1158/0008-5472.CAN-06-1822 ID - Yang2006 ER - TY - JOUR AU - Sideras, K. AU - Biermann, K. AU - Yap, K. PY - 2017 DA - 2017// TI - Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer JO - In J Cancer VL - 141 ID - Sideras2017 ER -